Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer-Reference-Cited by-同舟云学术

Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer

Published:2021-01-18 Issue:3 Volume:29 Page:336-348
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Dang Yi-Fan¹,Yang Shao-Hui²,Jiang Xiao-Ning¹,Gong Fu-Lian¹,Yang Xiao-Xia¹,Cheng Yan-Na¹,Guo Xiu-Li¹

Affiliation:

1. Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China

2. Shandong Wendeng Osteopathic Hospital, Wendeng, PR China

Funder

Natural Science Foundation of Shandong Province

Key Research and Development Program of Shandong Province

China Australia Centre for Health Science Research

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2020.1844216

Reference35 articles.

1. Moving towards successful penile transplantation programmes

2. Novel therapeutics for type 2 diabetes: insulin resistance

3. Recent Advances on the Role of microRNAs in both Insulin Resistance and Cancer

4. Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms

5. Insulin Resistance, Obesity, and Liver Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing drugs targeting metabolic diseases for cancer therapeutics;Drug Discovery Today;2023-09

2. Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database;Frontiers in Medicine;2023-07-19

3. ROSIGLITAZONE, A REPURPOSED DRUG AS ANTICANCER AGENT: A REVIEW;Towards Excellence;2023-06-30

4. 8-Hydroxyquinoline a natural chelating agent from Streptomyces spp. inhibits A549 lung cancer cell lines via BCL2/STAT3 regulating pathways;World Journal of Microbiology and Biotechnology;2022-08-12